Clinical Trial Update: Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than Four Years With Pancreatic Exocrine Insufficiency [Phase 3]

View source ↗

Summary

This Phase 3 trial assessed the safety and tolerability of Creon Micro in children under four with pancreatic exocrine insufficiency; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Exocrine Insufficiency

Drugs mentioned

• Creon Micro (pancrelipase)

Snippet

Sponsor: Abbott Products | Conditions: Pancreatic Exocrine Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2014-07-15